The Wall Street Journal:
If two start-ups have their way, videogames might cure more than just boredom. They could also be used to treat attention-deficit hyperactivity disorder.
Akili Interactive Labs Inc. of Boston, formed by start-up-creating firm PureTech Ventures, and San Francisco company Brain Plasticity Inc. are seeking Food and Drug Administration approval for a videogame treatment they hope clinicians will turn to before prescribing medicines for ADHD.
The disorder, whose symptoms include difficulty paying attention and remaining focused, affects 9% of adolescents and 4.1% of adults in the U.S., according to the American Psychiatric Association.
Read the whole story: The Wall Street JournalMore of our Members in the Media >